The indirect pathway in graft rejection

Abstract

This article reviews the evidence supporting the emerging view that 1) indirect responses play an important role in allograft rejection, 2) a limited number of major histocompatibility complex peptides are critical for stimulating indirect responses, and 3) major histocompatibility complex peptide therapy might, therefore, be useful in preventing allograft rejection.